To unsubscribe from receiving updates, enter your email address

Lexicon Pharmaceuticals, Inc., is committed to providing helpful and medically relevant information to individuals and members of the healthcare professional community. If you prefer not to receive future updates on XERMELO™ via the email address that you have previously used to subscribe with us, please enter the email address in the field above and click on the Submit button. If you wish not to receive any future communications from Lexicon Pharmaceuticals, please click here to view our Policies.

Social Image

Important Safety Information and Indication

Important Safety Information

  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops
  • The most common side effects of XERMELO include nausea, headache, increase in hepatic enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, and fever


XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

For more information about XERMELO, talk to your doctor or see Full Prescribing Information.